caseins has been researched along with camptothecin in 2 studies
Studies (caseins) | Trials (caseins) | Recent Studies (post-2010) (caseins) | Studies (camptothecin) | Trials (camptothecin) | Recent Studies (post-2010) (camptothecin) |
---|---|---|---|---|---|
16,863 | 561 | 4,170 | 13,002 | 2,229 | 5,391 |
Protein | Taxonomy | caseins (IC50) | camptothecin (IC50) |
---|---|---|---|
Histone deacetylase 3 | Homo sapiens (human) | 0.05 | |
Multidrug resistance-associated protein 4 | Homo sapiens (human) | 7.4 | |
DNA topoisomerase 1 | Homo sapiens (human) | 1.9799 | |
Somatostatin receptor type 1 | Homo sapiens (human) | 0.0022 | |
Somatostatin receptor type 2 | Homo sapiens (human) | 0.0022 | |
Somatostatin receptor type 4 | Homo sapiens (human) | 0.0022 | |
Somatostatin receptor type 3 | Homo sapiens (human) | 0.0022 | |
Somatostatin receptor type 5 | Homo sapiens (human) | 0.0022 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.97 | |
Histone deacetylase 4 | Homo sapiens (human) | 0.05 | |
Histone deacetylase 1 | Homo sapiens (human) | 0.05 | |
Histone deacetylase 7 | Homo sapiens (human) | 0.05 | |
Histone deacetylase 2 | Homo sapiens (human) | 0.05 | |
Polyamine deacetylase HDAC10 | Homo sapiens (human) | 0.05 | |
Histone deacetylase 11 | Homo sapiens (human) | 0.05 | |
Histone deacetylase 8 | Homo sapiens (human) | 0.05 | |
Histone deacetylase 6 | Homo sapiens (human) | 0.05 | |
Histone deacetylase 9 | Homo sapiens (human) | 0.05 | |
Histone deacetylase 5 | Homo sapiens (human) | 0.05 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Assaraf, YG; Epstein, D; Livney, YD; Shapira, A | 1 |
Khatun, S; Pebam, M; Putta, CL; Rengan, AK | 1 |
2 other study(ies) available for caseins and camptothecin
Article | Year |
---|---|
Beta-casein nanoparticles as an oral delivery system for chemotherapeutic drugs: impact of drug structure and properties on co-assembly.
Topics: Administration, Oral; Antineoplastic Agents; Camptothecin; Caseins; Colloids; Docetaxel; Drug Carriers; Drug Compounding; Drug Stability; Hydrogen-Ion Concentration; Irinotecan; Molecular Structure; Nanoparticles; Paclitaxel; Particle Size; Structure-Activity Relationship; Taxoids; Vinblastine | 2010 |
Camptothecin loaded casein nanosystem for tuning the therapeutic efficacy against highly metastatic triple-negative breast cancer cells.
Topics: Animals; Antineoplastic Agents; Camptothecin; Caseins; Cell Line, Tumor; Humans; Nanoparticles; Triple Negative Breast Neoplasms; Zebrafish | 2023 |